Xerostomia, salivary characteristics and gland volumes following intensity‐modulated radiotherapy for nasopharyngeal carcinoma: a two‐year follow up

BACKGROUND To evaluate changes in xerostomia status, salivary characteristics and gland volumes 2 years following radiotherapy in nasopharyngeal carcinoma patients. METHODS Xerostomia scores, salivary flow rates, pH and buffering capacity were measured at pre-radiotherapy, mid-radiotherapy, 2 weeks, 3 months and 2 years post-radiotherapy. Salivary gland volumes and their correlation with radiation dose were also assessed. RESULTS Mean radiation dose to oral cavity, parotid and submandibular glands (SMG) was 44.5, 65.0 and 38.6 Gy respectively. Parotid and SMG volumes decreased 33% at 3 months post-radiotherapy; volumes at 2 years post-radiotherapy were 84% and 51% of pre-radiotherapy levels, respectively. Correlations were observed between parotid gland volume per cent reduction and its radiation dose and between resting salivary flow rate reduction and post-radiotherapy/pre-radiotherapy SMG volume ratio. Salivary flow rates and resting saliva pH remained significantly low at 2 years post-radiotherapy (both flow rates, P = 0.001; resting saliva pH, P = 0.005). Similarly, xerostomia scores remained significantly higher compared with pre-radiotherapy levels. CONCLUSIONS Submandibular gland volumetric shrinkage persisted 2 years after radiotherapy. Xerostomia scores remained significantly higher, and salivary flow rates and resting saliva pH remained significantly lower, suggesting that study participants were still at risk for hyposalivation-related oral diseases.

[1]  N. Lee,et al.  Proton Therapy for Head and Neck Cancer , 2018, Current Treatment Options in Oncology.

[2]  Chaosu Hu,et al.  The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels , 2017, Radiation Oncology.

[3]  Thalita Santana,et al.  A closer look at strategies for preserving salivary gland function after radiotherapy in the head and neck region. , 2016, Oral oncology.

[4]  Edwin P Hui,et al.  Nasopharyngeal carcinoma , 2016, The Lancet.

[5]  Y. Mao,et al.  Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis , 2015, BMC Cancer.

[6]  G. Carpenter,et al.  Changes in Saliva Rheological Properties and Mucin Glycosylation in Dry Mouth , 2015, Journal of dental research.

[7]  Joseph O. Deasy,et al.  Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer , 2015, Science Translational Medicine.

[8]  B. Murphy,et al.  Dental demineralization and caries in patients with head and neck cancer. , 2015, Oral oncology.

[9]  A. Almståhl,et al.  Microflora in oral ecosystems and salivary secretion rates--A 3-year follow-up after radiation therapy to the head and neck region. , 2015, Archives of oral biology.

[10]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[11]  Johannes A Langendijk,et al.  Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  K. Ang,et al.  Clinical Investigation : Head and Neck Cancer A Phase II Study of Submandibular Gland Transfer Prior to Radiation for Prevention of Radiation-induced Xerostomia in Head-and-Neck Cancer ( RTOG 0244 ) , 2022 .

[13]  F. Feng,et al.  Clinical Investigation : Head and Neck Cancer Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer : Beyond Sparing the Parotid Glands , 2012 .

[14]  A. Earnest,et al.  Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence , 2012, BMC Cancer.

[15]  Laura Marucci,et al.  A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[16]  A. Vissink,et al.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life , 2010, Supportive Care in Cancer.

[17]  K. Vineberg,et al.  Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[18]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. Kent,et al.  Caries clinical trial of a remineralising toothpaste in radiation patients. , 2008, Gerodontology.

[20]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[21]  M. Brosky The role of saliva in oral health: strategies for prevention and management of xerostomia. , 2007, The journal of supportive oncology.

[22]  N. Pitts,et al.  Dental caries , 2007, The Lancet.

[23]  Tae Hyun Kim,et al.  Evaluation of parotid gland function following intensity modulated radiation therapy for head and neck cancer. , 2006, Cancer research and treatment : official journal of Korean Cancer Association.

[24]  W. Hinkelbein,et al.  Radiation-related damage to dentition. , 2006, The Lancet. Oncology.

[25]  Heikki Joensuu,et al.  Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  E. Pow,et al.  Oral health condition in southern Chinese after radiotherapy for nasopharyngeal carcinoma: extent and nature of the problem. , 2003, Oral diseases.

[28]  A. Vissink,et al.  Oral sequelae of head and neck radiotherapy. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[29]  W. Kuo,et al.  Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. , 2002, International journal of radiation oncology, biology, physics.

[30]  L. Dawson,et al.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. , 2001, International journal of radiation oncology, biology, physics.

[31]  J. Epstein,et al.  Compliance with fluoride gel use in irradiated patients. , 1995, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[32]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[33]  S. Macdonald,et al.  Caries prevalence in xerostomic individuals. , 1993, Journal.

[34]  C. Christensen,et al.  A Comparison of Whole Mouth Resting and Stimulated Salivary Measurement Procedures , 1982, Journal of dental research.

[35]  M. Myślińska [SALIVA AND DENTAL CARIES]. , 1965, Czasopismo stomatologiczne.

[36]  B. Murphy,et al.  Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement. , 2016, Critical reviews in oncology/hematology.

[37]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[38]  J. Ekstrand,et al.  Caries incidence, salivary flow rate and efficacy of fluoride gel treatment in irradiated patients. , 1994, Caries research.

[39]  J. Horiot,et al.  [Prevention of caries and osteonecrosis through daily local fluoridation in radiotherapy patients]. , 1977, Revue de stomatologie et de chirurgie maxillo-faciale.

[40]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .